Loberg Philip Walden Jr 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Jul 27, 2011
Insider Transaction Report
Form 4
Loberg Philip Walden Jr
EVP, Interim CFO
Transactions
- Award
Common Stock, no par value
2011-07-25+7,500→ 145,065 total
Footnotes (3)
- [F1]Represents Restricted Share Units received under an employee Share Matching Program ("Matching RSUs") in connection with the officer's purchase of Company common stock. Each Matching RSU represents a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.
- [F2]1/3 of the Matching RSUs will vest each on the first, second and third anniversary of the date of grant subject to contingent employment and retention of the corresponding purchased shares.
- [F3]This number includes 20,694 Performance based Restricted Share Units that were previously reported in Table I.